Estrella Immunopharma, Inc. Common Stock (ESLA) is a publicly traded Healthcare sector company. As of July 24, 2026, ESLA trades at $0.81 with a market cap of $32.75M and a P/E ratio of -2.22. ESLA moved +5.31% today. Year to date, ESLA is -51.00%; over the trailing twelve months it is -15.07%. Its 52-week range spans $0.73 to $3.15. Rallies surfaces ESLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $32.75M |
| P/E Ratio | -2.22 |
| EPS | $-0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.15 |
| 52-Week Low | $0.73 |
| Volume | 18.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.06M |
| Gross Margin | 0.00% |
ESLA analyst coverage data. Average price target: $0.00.